Rivaroxaban NOBEL 15 mg, Filmtabletten - 15 Swissmedic Key 68009004 Registration Holder NOBEL Pharma Schweiz AG Name Rivaroxaban NOBEL 15 mg, Filmtabletten Date of registration 28.04.2022 Introduction of Sequence 28.04.2022 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until 27.04.2027 Index Therapeuticus (BSV) Show package size 15 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680680090046 Medication Code Synthetika Pharmacode Disponibility
Composition rivaroxabanum 15 mg, mannitolum, carmellosum natricum conexum, hypromellosum, natrii laurilsulfas, cellulosum microcristallinum, magnesii stearas, Überzug: hypromellosum, macrogolum 3350, E 171, E 172 (rubrum), pro compresso obducto corresp. natrium max. 0.3292 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Rivaroxabanum 15 mg
Inactive agents Dose additional_information (Rubrum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hypromellosum Überzug Macrogol 3350 Magnesii Stearas Mannitol Natrii Laurilsulfas Pro Compresso Obducto
Source Data was imported : 05.05.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
